Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
Reactivation of hepatitis B virus (HBV; RHBV) is a significant concern during immunosuppressive therapy, as it can lead to severe hepatitis and liver failure. The article reports a case of RHBV during treatment with guselkumab, an interleukin-23 inhibitor in a patient with inactive HBV infection and...
Saved in:
Main Authors: | Elena Franchi, Arianna A. C. Costanzo, Carmela Cursaro, Amedeo Lonardo, Claudia Lasagni, Pietro Andreone |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2023-12-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100831/100831.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01) -
Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01) -
Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden
by: Cristina Bulai Livideanu, et al.
Published: (2025-02-01) -
A New Diagnosing Method for Psoriasis From Exhaled Breath
by: Bilge Han Tozlu, et al.
Published: (2025-01-01)